Item Type | Name |
Concept
|
Kidney Cortex
|
Concept
|
Kidney Diseases
|
Concept
|
Kidney Function Tests
|
Concept
|
Kidney Tubules
|
Concept
|
Chronic Kidney Disease-Mineral and Bone Disorder
|
Concept
|
Kidney
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
Kidney Transplantation
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
Concept
|
Acute Kidney Injury
|
Concept
|
Kidney Medulla
|
Academic Article
|
Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
|
Academic Article
|
Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol.
|
Academic Article
|
Increased risk of fracture in patients receiving solid organ transplants.
|
Academic Article
|
Role of interleukin-6 in beta2-microglobulin-induced bone mineral dissolution.
|
Academic Article
|
Analysis of fracture prevalence in kidney-pancreas allograft recipients.
|
Academic Article
|
Mechanism of transplantation-associated bone loss.
|
Academic Article
|
Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro.
|
Academic Article
|
Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
|
Academic Article
|
Beta(2)-microglobulin and bone cell metabolism.
|
Academic Article
|
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
|
Academic Article
|
Posttransplant bone disease: a case illustrating dramatic improvements in bone density with vitamin D replacement therapy.
|
Academic Article
|
Renal osteodystrophy in chronic renal failure.
|
Academic Article
|
Percutaneous bone biopsy in the diagnosis of renal osteodystrophy.
|
Academic Article
|
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
|
Academic Article
|
Osteoporosis in chronic kidney disease.
|
Academic Article
|
Bone disease after kidney transplantation.
|
Academic Article
|
Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.
|
Academic Article
|
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
|
Academic Article
|
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
|
Academic Article
|
Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from blood.
|
Academic Article
|
Bone disease after kidney transplantation.
|
Academic Article
|
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
|
Academic Article
|
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.
|
Academic Article
|
Bone health in chronic kidney disease-mineral and bone disease.
|
Academic Article
|
Mortality risk among hemodialysis patients receiving different vitamin D analogs.
|
Academic Article
|
Osteoporosis and chronic kidney disease.
|
Academic Article
|
Role of vitamin D deficiency in chronic kidney disease.
|
Academic Article
|
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
|
Academic Article
|
Advances in renal bone disease: osteoporosis and chronic kidney disease.
|
Academic Article
|
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
|
Academic Article
|
Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.
|
Academic Article
|
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
|
Academic Article
|
Use of vitamin D in chronic kidney disease patients.
|
Academic Article
|
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
|
Academic Article
|
When is Vitamin D contraindicated in dialysis patients?
|
Academic Article
|
Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?
|
Academic Article
|
Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
|
Academic Article
|
Bone disease in kidney transplant patients.
|
Academic Article
|
Renal bone disease.
|
Academic Article
|
Abnormal bone and mineral metabolism in kidney transplant patients--a review.
|
Academic Article
|
Beta2-microglobulin stimulates osteoclast formation.
|
Academic Article
|
Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
|
Academic Article
|
Evaluation of cinacalcet HCl treatment after kidney transplantation.
|
Academic Article
|
Greater inhibition of in vitro bone mineralization with metabolic than respiratory acidosis.
|
Academic Article
|
Hypocalcemia in end-stage renal disease: a consequence of spontaneous parathyroid gland infarction.
|
Academic Article
|
Sarcoidosis presenting as acute renal failure during pregnancy.
|
Academic Article
|
Maintenance of bone mass in patients receiving dialytic therapy.
|
Academic Article
|
Parathyroid hormone-mediated aluminum deposition and egress in the rat.
|
Academic Article
|
Role of IL-1 beta and prostaglandins in beta 2-microglobulin-induced bone mineral dissolution.
|
Academic Article
|
Role of bone biopsy in stages 3 to 4 chronic kidney disease.
|
Academic Article
|
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
|
Academic Article
|
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
|
Academic Article
|
Factors affecting tissue aluminum concentration.
|
Academic Article
|
Determinants of tissue aluminum concentration.
|
Academic Article
|
The role of the bone biopsy in the diagnosis of renal osteodystrophy.
|
Academic Article
|
Comparative cost-benefit analyses of paricalcitol and calcitriol in stage 4 chronic kidney disease from the perspective of a health plan.
|
Academic Article
|
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
|
Academic Article
|
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
|
Academic Article
|
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients.
|
Academic Article
|
Impact of CKD on coronary artery calcifications.
|
Academic Article
|
Is beta 2-microglobulin a mediator of bone disease?
|
Academic Article
|
Aluminum neurotoxicity: a reevaluation.
|
Academic Article
|
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
|
Academic Article
|
Use of vitamin D analogs in chronic renal failure.
|
Academic Article
|
Pharmacokinetics of icodextrin in peritoneal dialysis patients.
|
Academic Article
|
Clinical and economic burden of fractures in patients with renal osteodystrophy.
|
Academic Article
|
Variation in parathyroid hormone immunoassay results--a critical governance issue in the management of chronic kidney disease.
|
Academic Article
|
Renal function and risk of hip and vertebral fractures in older women: is it always osteoporosis?
|
Academic Article
|
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate.
|
Academic Article
|
CKD-mineral and bone disorder management in kidney transplant recipients.
|
Academic Article
|
Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?
|
Academic Article
|
Acute renal failure associated with cardiac operations. A case-control study.
|
Academic Article
|
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
|
Academic Article
|
Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
|
Academic Article
|
Women and CKD-mineral and bone disorder.
|
Academic Article
|
Painful skin ulcers in a hemodialysis patient.
|
Academic Article
|
A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.
|
Academic Article
|
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.
|
Academic Article
|
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD.
|
Academic Article
|
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
|
Academic Article
|
A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM).
|
Academic Article
|
Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study.
|
Academic Article
|
Renal Blood Oxygenation Level-Dependent Magnetic Resonance Imaging: A Sensitive and Objective Analysis.
|
Academic Article
|
A novel nervous system beta subunit that downregulates human large conductance calcium-dependent potassium channels.
|
Academic Article
|
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
|
Academic Article
|
We Do Too Many Parathyroidectomies for Calciphylaxis.
|
Academic Article
|
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
|
Academic Article
|
Imaging in Chronic Kidney Disease-Metabolic Bone Disease.
|
Academic Article
|
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data?.
|
Academic Article
|
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.
|
Academic Article
|
Evaluation of Renal Blood Flow in Chronic Kidney Disease Using Arterial Spin Labeling Perfusion Magnetic Resonance Imaging.
|
Academic Article
|
Mineral and Bone Disease in Kidney Transplant Recipients.
|
Academic Article
|
Consistency of Multiple Renal Functional MRI Measurements Over 18 Months.
|
Academic Article
|
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
|
Academic Article
|
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
|
Academic Article
|
Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD.
|
Academic Article
|
Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease.
|
Academic Article
|
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
|
Academic Article
|
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetesĀ and stage 4 chronic kidney disease.
|
Academic Article
|
Renal BOLD MRI in patients with chronic kidney disease: comparison of the semi-automated twelve layer concentric objects (TLCO) and manual ROI methods.
|
Academic Article
|
Interventions for Preventing Bone Disease Following Kidney Transplantation: Is There Evidence for Specific Therapy?
|
Academic Article
|
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.
|
Academic Article
|
Secondary Hyperparathyroidism in a Patient with CKD.
|
Academic Article
|
Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort Study.
|
Academic Article
|
The Enigma of Vascular Calcifications.
|
Academic Article
|
Medullary Blood Oxygen Level-Dependent MRI Index (R2*) is Associated with Annual Loss of Kidney Function in Moderate CKD.
|
Academic Article
|
Phosphate Balance and CKD-Mineral Bone Disease.
|
Academic Article
|
Family Genetic Screening to Identify Cases of Alport Syndrome: A Case Study Report.
|
Academic Article
|
Radiomics-Based Image Phenotyping of Kidney Apparent Diffusion Coefficient Maps: Preliminary Feasibility & Efficacy.
|
Academic Article
|
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism.
|
Academic Article
|
Quantitative Blood Oxygenation Level Dependent Magnetic Resonance Imaging for Estimating Intra-renal Oxygen Availability Demonstrates Kidneys Are Hypoxemic in Human CKD.
|
Academic Article
|
Response to Alkali Administration in Women and Men With and Without CKD.
|
Academic Article
|
Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet.
|
Academic Article
|
Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with Chronic Kidney Disease.
|